Abstract
Review question/objective What are the prognostic indicators predictive of chemotherapy-induced febrile neutropenia outcomes among adult cancer patients? Inclusion criteria Types of participants The participants of interest include adults, 18 years old and above with cancer, who developed febrile neutropenia as a result of myelosuppressive systemic chemotherapy either in an in-patient or outpatient setting. Types of intervention(s)/phenomena of interest The focus of this systematic review is on the prognostic indicators predictive of chemotherapy-induced febrile neutropenia outcomes in adult cancer patients. Types of Outcome(s) The primary outcome of this review is to identify the indicators predictive of FN outcomes (favourable or unfavourable) that influence the incidence of morbidity and mortality of adult cancer patients related to FN
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call